Organ transplant recipients are twice as likely to develop melanoma compared with people who do not receive a transplant, according to a new study published in the Journal of Investigative Dermatology.
MRV Research
New Combination Treatment Effective Against Melanoma
In findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research has shown.
Sunitinib Shows Activity in Mucosal, Acral Melanoma
Sunitinib showed activity in the treatment of mucosal and acral melanoma whether or not the patients had a KIT mutation, according to a new study published online ahead of print in the journal Cancer; however, it was poorly tolerated and no patient experienced a prolonged response.
FDA Delays Decision on Frontline Nivolumab in Melanoma
The FDA has extended the review period for frontline nivolumab (Opdivo) in patients with advanced melanoma by 3 months, to allow ample time to review additional data submitted by the PD-1 inhibitor’s developer Bristol-Myers Squibb (BMS). The updated action date for the new indication is November 27, 2015.